Pharmaceutical companies once considered a protein called p38 a very attractive target for treating rheumatoid arthritis. Arthritis patients usually have elevated activity of this inflammation-producing protein, and in lab ...
Mar 7, 2018
1
134
Researchers testing the head lice drug Ivermectin as a possible treatment for COVID-19 have seen promising results in lab studies.
Apr 6, 2020
0
29
Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.
Sep 4, 2011
3
0
Diabetes is a growing epidemic in the United States. Now the seventh leading cause of death, the condition plagues more than an estimated 29 million Americans, according to the Centers for Disease Control and Prevention—and ...
Nov 16, 2016
0
0
James McKerrow, MD, Ph.D., dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has long studied neglected tropical diseases—chronic and disabling parasitic infections ...
Apr 2, 2021
0
79
National Institutes of Health researchers and their colleagues have identified how resveratrol, a naturally occurring chemical found in red wine and other plant products, may confer its health benefits. The authors present ...
Feb 2, 2012
2
0
Antibiotics for acute infections are a pillar of medicine, but doctors say the pillar is crumbling as pharmaceutical companies neglect antibiotic development and instead chase massive profits from chronic illnesses and lifestyle ...
Nov 22, 2011
60
0
(HealthDay)—For people with psoriasis, "freedom from disease" is a multicomponent concept that includes five main domains, according to research published online Nov. 24 in the Journal of the European Academy of Dermatology ...
Dec 21, 2021
0
12
If you have just had knee, shoulder or hip surgery, you may want to take anti-inflammatories in the morning or at noon, but not at night. A McGill-led study shows, for the first time, that circadian clock genes are involved ...
Jan 21, 2020
0
141
Awakening the immune system's instinct for destroying cancer, using two molecules located on the surface of macrophages: that's the promising avenue opening up from recent laboratory work of Dr. André Veillette.
Jan 18, 2022
0
108
